3 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2227400/henry-schein-hsic-set-to-post-q4-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227400
Feb 16, 2024 - Henry Schein's (HSIC) fourth-quarter 2023 results are likely to reflect the resiliency of the dental and medical markets amid macroeconomic challenges.
zc:-5587068660419963111
0
https://www.zacks.com/stock/news/2201157/henry-schein-hsic-enters-orthopedic-market-with-new-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201157
Dec 21, 2023 - Henry Schein's (HSIC) recent deals will position it as a prominent producer and supplier in the orthopedic market's Foot and Ankle, Hand and Wrist extremity sectors.
zc:-6578043116322813966
0
https://www.zacks.com/stock/news/2193401/henry-schein-s-hsic-zahn-dental-and-myerson-enter-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193401
Dec 05, 2023 - Henry Schein's (HSIC) dental laboratory business, Zahn Dental, is set to exclusively distribute Myerson's New Trusana 3D Premium Denture System.
zc:2203851533293633074
0